Astera Labs, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
ALAB
Astera Labs, INCStefan A Dyckerhoff, a Director of Astera Labs, Inc., sold 12,499 shares of common stock on August 6, 2026.
NASDAQ
ALAB
Astera Labs, INCGermaine Cota, Chief Accting. Off. & VP, Fin. of Astera Labs, Inc., received 1,451 shares of common stock on July 20, 2026.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba has sold a significant number of shares through a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment strategy.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba reports significant stock sales executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba reports significant sales of company stock executed under a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Stefan A. Dyckerhoff reported the sale of common stock valued at approximately $450 per share under a pre-arranged trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Bethany Mayer has sold a significant number of company shares through a pre-arranged trading plan, as disclosed in a Form 4 filing.
NASDAQ
ALAB
Astera Labs, INCDirector Jack R. Lazar sold shares of Astera Labs, Inc. following a scheduled RSU grant and pre-arranged trading plan.
NASDAQ
ALAB
Astera Labs, INCDirector Michael E. Hurlston was granted 837 restricted stock units as part of the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCDirector Craig H. Barratt was granted 837 restricted stock units as part of the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCDirector Bethany Mayer was granted 837 restricted stock units as part of the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCDirector Stefan Dyckerhoff sold 12,499 shares of Astera Labs common stock via a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs President and COO Sanjay Gajendra reported the sale of over 600,000 shares of common stock, executed through a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCForm 4: Astera Labs Officer Sells Shares
Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., reported a transaction involving the sale of common stock.
NASDAQ
ALAB
Astera Labs, INCAstera Labs President and COO Sanjay Gajendra sold 280,000 shares of common stock via a pre-arranged 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold approximately 77,000 shares to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
ALAB
Astera Labs, INCAstera Labs President and COO Sanjay Gajendra sold shares to satisfy tax obligations related to RSU vesting.
NASDAQ
ALAB
Astera Labs, INCAstera Labs General Counsel Philip Mazzara sold shares to satisfy tax obligations following the vesting of restricted stock units.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold approximately 140,000 shares of common stock via a pre-arranged 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCForm 4: Astera Labs Insider Buys Shares
Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., acquired 131 shares of common stock through an employee stock purchase plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs President and COO Sanjay Gajendra executed a series of planned stock sales totaling over 49,000 shares through estate planning trusts.
NASDAQ
ALAB
Astera Labs, INCAstera Labs President and COO Sanjay Gajendra executed a series of stock sales totaling over 180,000 shares via a 10b5-1 plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 128,147 shares of common stock on May 7, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCDirector Stefan Dyckerhoff sold a total of 12,499 shares of Astera Labs, Inc. common stock on May 7, 2026, pursuant to a Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CFO Desmond Lynch was granted 49,584 restricted stock units as part of the company's 2024 incentive plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 301,574 shares of common stock via a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCDirector Stefan Dyckerhoff sold a total of 25,764 shares of Astera Labs common stock across multiple transactions in April 2026.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 2,967 shares of common stock on April 15, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan has sold a significant number of company shares through a pre-arranged trading plan, as disclosed in a Form 4 filing.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba sold a significant number of shares in multiple transactions executed under a pre-arranged Rule 10b5-1 trading plan.